On Target Laboratories

📍 West Lafayette, United States🗓 Founded 2010👥 44 employees💰 Last funded Jun 2018
On Target Laboratories discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery so cancerous tissue can be removed more completely. To date, there has been no reliable way for surgeons to assess the location and full extent of cancerous tissue while operating. Our molecular imaging technology, based on the pioneering work of Philip S. Low, PhD, Purdue Universitys Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, aims to reduce the uncertainty associated with finding and removing cancerous tissue during surgical procedures, helping surgeons to provide a more precise and complete surgical resection. Visit our website to learn more about On Target Laboratories and our targeted intraoperative molecular imaging agents.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2010
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in On Target Laboratories?
On Target Laboratories has 1 investors on record on gritt.io and 1 late-stage investors.
When did On Target Laboratories last raise funding?
The most recent investment in On Target Laboratories recorded on gritt.io was in June 2018.
When was On Target Laboratories founded?
On Target Laboratories was founded in 2010.
What industry is On Target Laboratories in?
On Target Laboratories operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is On Target Laboratories based?
On Target Laboratories is headquartered in West Lafayette, United States.